Company
35Pharma
35Pharma is a biopharmaceutical company focused on designing and developing innovative biologics for diseases with high unmet medical need.
Also known as 35Pharma Inc
- Status
- Acquiredas of 2026-09-20Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Mississauga, ON, Canada
- Legal name
- 35Pharma Inc
- 35pharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At 35Pharma, we are dedicated to designing and developing best-in-class ligand traps that target Activin x GDF biology and address diseases with high unmet medical need including pulmonary hypertension, heart failure and obesity.
Funding snapshot
- Latest round
- Series C2024-11-26
Funding rounds
- Series C
- 2024-11-26
About the company
- Status notes
- GSK has acquired 35Pharma.
Products
- Other
- HS235
Exit
- Acquisition
- 2026-02-25
Loading relationship preview